INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 41 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $0 | – | 509 | +0.2% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 508 | -33.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 758 | +250.9% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 216 | -83.6% | 0.00% | – |
| Q1 2017 | $5,000 | -44.4% | 1,321 | -38.2% | 0.00% | – |
| Q4 2016 | $9,000 | +800.0% | 2,137 | +2037.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -75.0% | 100 | -82.4% | 0.00% | – |
| Q1 2016 | $4,000 | 0.0% | 569 | -0.9% | 0.00% | – |
| Q4 2015 | $4,000 | -75.0% | 574 | -69.5% | 0.00% | – |
| Q3 2015 | $16,000 | -54.3% | 1,880 | -12.8% | 0.00% | – |
| Q2 2015 | $35,000 | – | 2,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|